Replies to post #278164 on Anavex Life Sciences Corp (AVXL)

[abew4me]

They're cutting it close.

EXPIRATION

Priority review vouchers do not expire. Furthermore, the priority review voucher program for neglected diseases (enacted in 2007) does not sunset. However, the program for rare, pediatric diseases will expire in October 2020, although a drug designated as a rare pediatric treatment can still receive a voucher if the drug is approved by October 2022. Furthermore, the program can be renewed, and Congress has renewed the program several times already.


Actual Study Start Date : July 1, 2020
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : July 2021